Starting in October 2022, EUGOGO will host a monthly webinar series dedicated to Graves' Orbitopathy.
Next webinar: October, 09 th 2023, 3-4pm CET
Diplopia negatively impacts the quality of life of patients with Graves' orbitopathy. Medical therapy, with the exception of some new immunomodulatory drugs, usually has little impact in improving diplopia. To date, surgery remains the definitive solution to diplopia, however with some limitations. The pre-operative orthoptic and strabologic evaluation is crucial.
Anja Eckstein, Essen
Andrea Papp, Vienna
Nicola Curro, Milan
Graves’ Orbitopathy (GO), also known as thyroid eye disease, or dysthyroid orbitopathy is a disease of the orbit affecting the orbital soft tissues. It is a possible cause of visual deterioration and double vision and is closely correlated to autoimmune thyroid dysfunctions, particularly with Basedows’ or Graves’ disease (GD).
EUGOGO is a multidisciplinary Scientific Society of ophthalmologists, endocrinologists, basic scientists and (neuro-)radiologists who have a special clinical and research interest in GO with the overriding goal of improving patient care.
All members are well recognized for their high level of experience in this field and their clinic represents a tertiary referral centre for GO connecting involved medical disciplines in their multidisciplinary Combined Thyroid Eye Clinics.
EUGOGO aims to contribute to a better understanding of the pathogenesis of GO and thus promotes the development of new beneficial therapies and their translation into clinical practice. This can only be achieved through collaborative multicentric and multidisciplinary scientific basic and clinical research.
EUGOGO contributes towards education, teaching and training of our young colleagues in our clinics and all interested health professionals involved in the care of patients with GO in our annual teaching courses around Europe.
Email address: firstname.lastname@example.org
Bank account n°: 0701362
In the name of: European Group on Graves Orbitopathy (please DO NOT USE the acronym EUGOGO)